Autres langues Rallybio Corporation

Actions

RLYB

US75120L1008

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
1,83 ^USD	0,00 %		+7,65 %	-23,43 %

17/04	Ralebio Corporation annonce la présentation des résultats d'une revue systématique de la littérature et d'une méta-analyse sur la FNAIT lors de la réunion annuelle de l'Academy of Managed Care Pharmacy 2024	CI
12/04	Les principales baisses du prémarché	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting	17/04
Ralebio Corporation Announces the Presentation of Results from FNAIT Systematic Literature Review and Meta- Analysis At the Academy of Managed Care Pharmacy 2024 Annual Meeting	17/04
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB	15/04
Top Premarket Decliners	12/04
US Equity Markets Close Mixed After March Producer Price Inflation Data	11/04
Sector Update: Health Care Stocks Softer Late Afternoon	11/04
Aktien New York: Dow erholt sich vor Start in die Berichtssaison	11/04
Top Midday Gainers	11/04
Aktien New York: Dow schwächer vor Start in die Berichtssaison	11/04
Aktien New York Ausblick: Vor dem Start in die Berichtssaison stabil erwartet	11/04
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Another Key Inflation Report	11/04
Top Premarket Gainers	11/04
Rallybio Corporation Announces Collaboration with Johnson & Johnson	10/04
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)	10/04
Rallybio Corporation announced that it has received $6.599999 million in funding from Johnson & Johnson Innovation - JJDC, Inc.	10/04
Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting	01/04
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results	12/03
Rallybio Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Rallybio Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/03
North American Morning Briefing : Stock Futures -2-	11/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Rallybio Corporation

Actions

RLYB

US75120L1008

Autres langues

Filtres